HNF1B and Hyperglycemia: In the PERT group, 9 subjects (19%: 2 subjects with T1D, 3 with pancreatogenic diabetes, 2 with MODY HNF-1B and one undetermined) had notable hyperglycemia in the months after PERT initiation.